Acambis Live Smallpox Vaccine Wins FDA Approval
This article was originally published in The Pink Sheet Daily
Executive Summary
ACAM2000 gained unanimous support of FDA’s Vaccines and Related Biological Products Advisory Committee in May.
You may also be interested in...
Stockwatch: Earnings Season Catches An Early Cold As Coronavirus Sweeps In
As industry bellwether J&J kicked-off 2019 fourth-quarter and full-year earnings season for life sciences companies, its financial results left investors feeling the cold. But with coronavirus envy sweeping a raft of smaller biotech companies, J&J may have the last laugh.
Sanofi Pasteur Will Fund Development Of Acambis West Nile Vaccine
Acambis is hoping to accelerate development of ChimeriVax and be first to market with a West Nile vaccine after inking an agreement with Sanofi Pasteur that includes $10 million upfront and $70 million in milestones.
Sanofi Pasteur Will Fund Development Of Acambis West Nile Vaccine
Acambis is hoping to accelerate development of ChimeriVax and be first to market with a West Nile vaccine after inking an agreement with Sanofi Pasteur that includes $10 million upfront and $70 million in milestones.